Benzinga's Top Upgrades

Analysts at Morgan Stanley upgraded Valeant Pharmaceuticals International VRX from “equal-weight” to “overweight.” The target price for Valeant Pharmaceuticals is set to $145. Valeant's shares closed at $125.35 yesterday. Deutsche Bank upgraded Hershey Company (The) HSY from “hold” to “buy.” The target price for Hershey has been raised from $90 to $108. Hershey's shares closed at $97.00 yesterday. Analysts at Citigroup upgraded The NASDAQ OMX Group NDAQ from “neutral” to “buy.” The target price for NASDAQ OMX Group has been raised from $40 to $50. NASDAQ OMX Group's shares closed at $40.07 yesterday. JP Morgan upgraded Rite Aid RAD from “neutral” to “overweight.” The target price for Rite Aid has been raised from $6 to $6.50. Rite Aid's shares closed at $5.31 yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesAnalyst Ratingstop upgrades
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!